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1. Introduction 
Fournier’s gangrene is a necrotising fasciitis of the genitalia. Jean Alfred Fournier (1832-
1914) was the first French syphilologist, the first professor of cutaneous and syphilitic 
diseases at the Paris Faculty of Medicine, and the most prominent European venereologist of 
the second half of the 19th century. He first described idiopathic, rapily progressive 
necrotizing gangrene of the male genitalia in 1883 and emphasised three characteristics; 
abrupt onset of scrotal pain and swelling in a healthy young man, rapid progression to 
gangrene, and the absence of a definitive cause (Fournier, 1883). Fournier’s original 
description included five otherwise healthy young males with scrotal gangrene and 
emphasised the sudden onset and rapid progression of the disease. Over the years several 
terms have been applied to Fournier’s gangrene including ‘streptococcus gangrene’, 
‘necrotising fasciitis’, ‘periurethral phlegmon’, ‘phagedena’ and ‘synergistic necrotising 
cellulitis’ (Eke, 2000). Although originally described in healthy young men Fournier’s 
gangrene is frequently seen in elderly patients as well as children (Woodside, 1980) and 
women (Lowthian and Gillard Jr, 1980).  
2. Pathophysiology 
Initially described as an idiopathic entity, a source of infection can now be identified in the 
majority of cases. Perineal and genital skin infections comprise most of the sources 
identified but anorectal or urogenital trauma, diverticular disease, pelvic and perineal injury 
and pelvic intervetions are other causes of Fournier s gangrene (Thwaini et al., 2006). In a 
large case series by Eke the distribution of the source of sepsis was 24% dermatological, 21% 
colorectal, 19% urological and unknown in 34% of patients (Eke, 2000). Whilst this condition 
does continue to effect healthy young men, the mean age of patients is between 50-65 years 
of age. Most patients have associated co-morbidities such as diabetes, alcoholism or HIV 
infection (Kuo et al., 2007). Diabetes is reported to be present in 20%-70% of patients with 
Fournier’s gangrene (Morpurgo, 2002) and chronic alcoholism in 25%-50% of cases (Clayton 
et al., 1990).  
The disease is believed to be an obliterative end-arteritis caused by the spread of micro-
organisms. Inflammation and oedema from infection results in an impaired local blood 
supply, leading to vascular thrombosis in the cutaneous and subcutaneous tissues. Peri-
fascial dissection with subsequent spread of bacteria and progression to gangrene of the 
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overlying tissues ensues (Levenson et al., 2008). The rate of fascial necrosis has been 
estimated to be as high as 3 cm per hour making early diagnosis crucial (Safioleas et al., 
2006). The subcutaneous infection with oedema and inflammation in an enclosed space 
impairs the blood supply and the resulting hypoxia permits the growth of facultative and 
obligatory anaerobes. These anaerobic micro-organisms produce hydrogen and nitrogen 
that accumulate in subcutaneous tissues resulting in crepitus (Hejase et al., 1996). The 
presence of subcutaneous emphysema signifies anaerobic conditions in the affected area 
(Wolach et al., 1989). Deeper infection that extends below the facial layers to involve 
myonecrosis not generally thought to be a feature of classical Fournier’s gangrene, although 
it has been described (Rye et al., 1987).  
Testicular involvement is rare in Fournier’s gangrene because of the separate blood supply 
to the testes (Gupta et al., 2007). In a retrospective review of 29 patients over a 13-year 
period Baskin et al. reported that only three patients underwent orchidectomy due to 
testicular gangrene (Baskin et al., 1990). Ayan et al reviewed 41 cases of Fournier’s gangrene 
and found that a bilateral orchidectomy was performed in 4 patients and a unilateral 
orchidectomy was performed in 5 patients (Ayan et al., 2005). In his large review of 1726 
patients Eke suggested that when testicular involvement does occur it indicates a 
retroperitoneal or intra-abdominal source of infection (Eke, 2000). Penis involvement is also 
rare and the corpora are usually spared while the skin sloughs off. Thrombosis of the corpus 
spongiosum and cavernosum has, however, been reported (Campos and Martos, 1990). 
3. Bacteriology 
There have been many types of bacteriological culture encountered in Fournier’s gangrene, 
both single strain and polymicrobial culture. In their experience of 38 patients Hejase et al 
found that 90% of the patients grew polymicrobial flora, including gram-positive and gram-
negative rods and gram-positive cocci. The main strains grown were Staphylococcus aureus, 
β-hemolytic Streptococcus, Pseudomonas sp., E. coli and Klebsiella sp. (Hejase et al., 1996). 
In 5% of their cases no growth was reported. Korkut et al had a 64% positive culture rate of 
the 36 patients in their case series who had cultures sent during their initial debridement, 
and the leading mircro-organism was Escherichia coli (Korkut et al., 2003). In their review of 
70 patients with Fournier’s gangrene Ersay et al found that the most frequent bacterial 
organisms cultured from the wounds were Escherichia coli (40.0%), Bacteroides spp. 
(38.6%), Streptococcus spp. (37.1%), Enterococcus spp. (27.1%), Staphylococcus spp. (25.7%), 
Pseudomonas spp. (24.3%), Klebsiella pneumoniae (20.0%), and Proteus spp. (18.6%). The 
bacterial organisms cultured from wound however were not independent predictors of 
outcome (Ersay et al., 2007). Kuo et al cutured a variety of oganisms in their series of 44 
patients in northern Taiwan (Kuo et al., 2007). These were cultured from necrotic tissue or 
pus during surgery or at the bedside. Only 1 organism was identified in 13 patients whilst 
culture results in 28 patients demonstrated polymicrobial infection.  In 3 patients wound 
cultures were negative. The most commonly isolated organisms from wound were 
Escherichia coli in 26 patients, Bacteroides fragilis in 17 patients, Klebsiella pneumoniae in 
16 patients, Enterococcus spp. in 14 patients and Proteus mirabilis in 10 patients. Similar to 
the case series by Ersay et al, mortality was not related to the specific isolated organism. In 
their review of 43 reconstructive patients Ferreira et al had a positive culture from 35 of the 
43 patients, with 29 (82.9%) of these being polymicrobial (Ferreira et al., 2007). The most 
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common orgaisms isolated were Staphylococcus aureus (21 patients), Escherichia coli and 
Pseudomonas aeruginosa (11). 
In their review article on Fornier’s gangrene Thwaini et al state that “cultures from the 
wounds commonly show polymicrobial infections by aerobes and anaerobes, which include 
coliforms, klebsiella, streptococci, staphylococci, Clostridia, Bacteroides and Cornybacteria. 
On average, at least three organisms are cultured from each diagnosed patient” (Thwaini et 
al., 2006). Along with the above organisms mentioned there have been cases reported of 
Fournier’s gangrene caused by unusual organisms such as Clostridium perfrinogens 
(Korhonen et al., 1998) and Clostridium tetani (Omotoso, 1990). 
4. Clinical 
The clinical features of Fournier’s gangrene include sudden pain in the scrotum, prostration, 
pallor and pyrexia. At first only the scrotum is involved, but if unchecked, the cellulitis 
spreads until the entire scrotal coverings slough, leaving the testes exposed but healthy 
(Russell et al., 2000). The presentation may also be insidious as opposed to the classical 
sudden onset presentation. One overwhelming feature of the presentation is the strong 
‘repulsive, fetid odour’ that is associated with the condition (Randall, 1920). Patients can 
present with varying signs and symptoms including fever greater than 38°C, scrotal 
swelling and erythema, purulence or wound discharge, crepitation or fluctulance (Ozden 
Yeniyol et al., 2004). In their case series Ferreira et al found that the most common 
presentations were scrotal swelling, fever and pain. The mean interval between initial 
symptoms and arrival at the hospital was 5.1 ± 3.1 days. Scrotal involvement was found in 
93.3% of cases, the penis was involved in 46.5% of cases, and the perineum or peri-anal 
region was involved in 37.2% of cases (Ferreira et al., 2007). Ersay et al found that the most 
common presentation was peri-anal/scrotal pain (78.6%) followed by tachycardia (61.4%), 
purulent discharge from the perineum (60%), crepitus (54.3%) and fever (41.4%) (Ersay et 
al., 2007). Crepitus of the inflamed tissue is a common feature of the disease due to the 
presence of gas forming organisms. As the subcutaneous inflammation worsens, necrotic 
patches start appearing over the overlying skin and progress to extensive necrosis (Laucks 
2nd, 1994). The spread if infection is along the facial planes and is usually limited by the 
attachment of the Colles’ fascia in the perineum (Thwaini et al., 2006). Infection can spread 
to involve the scrotum, peinis and can spread up the anterior abdominal wall, up to the 
clavicle (Saijo et al., 1990). As mentioned previously testicular involvement is rare in 
Fournier’s gangrene because of the separate blood supply to the testes, although it can occur 
and result in unilateral or bilateral orchidectomy. 
5. Differential diagnosis 
Although the diagnosis of Fournier’s gangrene is usually obvious due to the gangrene, 
patients may present at an earlier stage with an acutely swollen tender scrotum. Differential 
diagnoses in this scenario include intra-testicular injuries such as fracture and haematoma, 
extra-testicular injuries including haematomas or hematoceles, torsion of the spermatic cord, 
haemmorhage and necrosis of a testicular tumour, strangulated scrotal hernia, and 
inflammatory disease (Begley et al., 1988). Aside from the rare abscess or granulomatous 
infection the majority of inflammatory diseases affecting the scrotum are epididymitis and 
epididymo-orchitis. 
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6. Investigations 
The diagnosis of Fournier’s gangrene is primarily clinical. Imaging modalities may be 
helpful in those where the presentation is atypical or when there is concern regarding the 
true extent of the disease (Thwaini et al., 2006). Ultrasound has been shown to be effective in 
demonstrating specific features of Fournier’s gangrene, although CT has greater specificity 
for evaluating the disease. Unlike other conditions that cause acute scrotal pain, in 
Fournier’s gangrene the scrotal contents- the testes and epididymides- are normal, and no 
masses or other abnormal structures are present. Instead the ultrasound characteristics of 
Fournier’s gangrene include marked thickening of scrotal skin and, most significantly, air in 
the subcutaneous tissues. If the patient has more advanced disease, the skin thickening and 
subcutaneous air can be traced from the scrotum with ultrasound to demonstrate it’s full 
extent (Begley et al., 1988). Because the majority of cases of Fournier’s gangrene are not 
primary and are secondary to other conditions described earlier (e.g. diverticulitis), CT 
plays an important role in the diagnosis as well as the evaluation of disease extent for 
appropriate surgical treatment. In their review of the role of imaging in Fournier’s gangrene, 
Levenson et al describe the CT features seen in the disease: “The CT features on Fournier’s 
gangrene include soft-tissue thickening and inflammation. CT can demonstrate asymmetric 
fascial thickening, any co-existing fluid collection or abscess, fat stranding around involved 
structures, and subcutaneous emphysema secondary to gas-forming bacteria. The 
subcutaneous emphysema in Fournier’s gangrene dissects along fascial planes and can 
extend from the scrotum and perineum to the inguinal regions, thighs, abdominal wall, and 
retroperitoneum. The underlying cause of Fournier’s gangrene, such as perianal abscess, a 
fistulous tract, or an intra-abdominal or retroperitoneal infection process may also be 
demonstrated on CT. In cases caused by colonic perforation, not only does CT demonstrate 
extraluminal foci of air, but extravasation of enteric contrast material may also be seen” 
(Levenson et al., 2008). Features of Fournier’s gangrene can also be seen on plain 
radiography with hyperlucencies representing soft-tissue gas seen overlying the scrotum or 
perineum. Subcutaneous emphysema may also be seen within the soft tissues. Deep fascial 
gas is rarely seen at plain film radiography, which represents a significant weakness of this 
modality in the diagnosis and evaluation of Fournier’s gangrene (Wysoki et al., 1997). 
Routine blood investigations should be sent including a FBC, urea & electrolytes, C-Reactive 
Protein (CRP), glucose, and Arterial Blood Gas (ABG). The LRINEC (Laboratory Risk 
Indicator for Necrotizing Fasciitis) is a robust laboratory measurement score capable of 
determining even clinically early cases of necrotizing fasciitis (Wong et al., 2004). Using 
logistic regression analysis of independent variables from 89 cases of necrotizing fasciitis 6 
factors were identified to be independent predictors. A summary table of these variables is 
shown below in Table 1. 
Of the cohort of 89 patients only 13 (14.6%) patients had a diagnosis or suspicion of 
necrotizing fasciitis on admission. A majority were therefore missed, resulting in delayed 
operative debridement. In contrast, 80 (89.9%) of these patients had a LRINEC score of ≥6. 
According to Wong et al the biochemical and hematologic changes in necrotizing fasciitis 
develop early in the evolution of the disease and the LRINEC score can stratify patients into 
high and moderate risk categories even when the clinical picture is still equivocal.  
Laor et al determined outcome predition on 30 patients with Fournier’s gangrene and 
proposed a Fourner’s gangrene severity index (Laor et al., 1995). Admission laboratory 
parameters that were statistically related to outcome included hematocrit, blood urea  
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Variable, Units Score 
C-Reactive Protein, mg/L 
<150 
≥150 
 
0 
4 
Total white cell count, per mm3 
<15 
15-25 
>25 
 
0 
1 
2 
Haemoglobin, g/dL 
>13.5 
11-13.5 
<11 
 
0 
1 
2 
Sodium, mmol/L 
≥135 
<135 
 
0 
2 
Creatanine, μmol/L 
≤141 
>141 
 
0 
2 
Glucose, mmol/L 
≤10 
>10 
 
0 
1 
Table 1. Summary of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score. 
A LRINEC score of ≥6 should raise the suspicion of necrotizing fasciitis among patients with 
severe soft tissue infections, and a score ≥8 is strongly predictive of this disease (Wong et al., 
2004). 
nitrogen, calcium, albumin, alkaline phospatase and cholesterol levels. White blood count, 
platelets, potassium, bicorbonate, blood urea nitrogen, total protein, albumen and lactic 
dehydrogenise levels one week following hospitalization were also associated with 
outcome. These levels combined with the acute physiology and chronic health evaluation II 
severity score was used to create the Fournier’s gangrene severity index. The authors found 
that using a threshold of 9 on the severity index there was a 75% probability of death with a 
score greater than 9, while a score less than 9 was associated with a 78% probability of 
survival (p=0.008). 
7. Treatment 
The cornerstones of treatment of Fournier’s gangrene are urgent surgical debridement of all 
necrotic tissue as well as high doses of broad-spectrum antibiotics. Urgent resuscitation with 
fluids as well as blood transfusions may be needed. Empirical broad spectrum antibiotics 
should be initiated regardless of the Gram-stain and culture results, and the antibiotics 
chosen should cover streptococci, staphylococci, gram-negative Coliforms, Pseudomonas, 
Bacteroides and Clostridia (Laucks II, 1994).  Early surgical debridement is the primary aim 
of treatment and if delayed will have a negative impact on prognosis (Elliott et al., 2000). 
www.intechopen.com
 
Gangrene – Current Concepts and Management Options 
 
24
The goal of surgery is to excise all non-viable tissue until well-perfused viable tissue is 
reached. The subcutaneous disease may be more extensive than the cutaneous involvement 
and more radial debridement may need to be undertaken than originally planned pre-
operatively. Care must be taken not to open up deeper fascial planes that were not originally 
involved. Depending on the original foci of the disease, urinary or faecal diversion may be 
necessary. Multiple debridements of necrotic tissue are the rule rather than the exception. 
As mentioned previously, orchidectomy is a rare but sometimes necessary eventuality of 
extensive Fournier’s gangrene. 
Once the infection has subsided the scrotum has traditionally been left to heal by secondary 
intention as it has been noted to possess a remarkable ability to regenerate and heal 
(Thomas, 1956). The use of skin grafts and flaps are common to provide coverings of 
debrided tissue. In their review of 43 reconstructive cases Ferreira et al performed surgical 
debridement of scrotal, penile, and perineal necrosis along with other involved areas in all 
patients, including seven patients who required debridement twice, and one patient who 
required debridement three times (Ferreira et al., 2007). All patients received delayed 
surgical reconstruction after the appearance of healthy granulation tissue at the base of the 
wound. The mean time between the last debridement performed and the first reconstruction 
was 37.4 days. In total, 61 reconstructive procedures were performed in the 43 patients with 
up to four operations being performed on each patient. The superomedial thigh flap was 
performed for scrotum reconstruction in 26 patients. Split-thickness skin grafts were the 
major solution for covering penile skin losses. In four patients with urethral stricture, tubed 
urethroplasty was performed using free full-thickness skin grafts. Mean hospital stay was 
73.6 ± 42.5 days. 
Along with the increased use of skin flaps & grafts to cover bare areas after surgical 
debridement, the use of vacuum-assisted closure (VAC) has increased in popularity and 
aided the healing process in patients with Fournier’s gangrene. In their case series of 35 
patients with Fournier’s gangrene who received surgical debridement of necrotic areas, 
Czymek et al compared patients who were treated with conventional dressings to those who 
received VAC dressings over an 11 year period (Czymek et al., 2009). In the conventional 
dressings group, patients had their dressings changed once per day until the wounds were 
clean and healthy and local wounds could be closed with meshed grafts or flaps. In the VAC 
therapy group the VAC dressing was initiated 3-5 days after primary debridement. 
Continuous negative pressure of 75 mmHg was applied to the wounds and the VAC was 
changed every 48 hours. Similar to the conventional dressing group, the VAC therapy was 
continued until the wounds were healthy and clean and could be closed with meshed grafts 
or advancement flaps. Although the VAC therapy group was associated with significantly 
longer hospitalization is was also associated with lower mortality. Although the authors 
state that their study does not demonstrate that VAC dressings are superior to conventional 
dressings in terms of length of stay or clinical outcome, they state that “experience has 
shown that vacuum dressings are clinically effective and successfully used in the 
management of large wounds”. It is important to note that although this study did compare 
two groups it was not randomized, although the authors do address this point by correctly 
stating that it would be practically impossible to perform a randomized controlled trial on 
this group of patients because of the rarity of Fournier’s gangrene. 
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8. Complications  
The complications of Fournier’s gangrene can include single or multi-organ failure, as well 
as large scrotal, peri-anal, penile and abdominal wall skin defects. As mentioned previously, 
Fournier’s gangrene may involve the testes, and single or bilateral orchidectomy may need 
to be performed. The penis may need to be partially or completely amputated in cases of 
severe gangrene (Schneider et al., 1986). Fournier’s gangrene may be the presenting feature 
of diabetes mellitus, and may be associated with keto-acidosis (Slater et al., 1982). Long-term 
pain is not uncommon in Fournier’s gangrene and 50% of patients can be expected to be free 
of pain. The sexual function may be impaired by penile deviation or penile torsion as well as 
loss of sensitivity to the penile skin or pain during erection (Ferreira et al., 2007). Infertility is 
rare after Fournier’s gangrene, but has been reported (Baskin et al., 1990). 
9. Conclusion 
Fournier’s gangrene is a rare necrotising fasciitis of the genitalia originally described in 
healthy young men. Recent evidence has shown that a cause for the condition can be 
identified in most patients and today’s cohort are unlikely to be healthy young men but 
elderly patients with co-morbid conditions such as diabetes, immunosuppression or 
alcoholism. The most common sources of infection are perineal and genital skin infections, 
although other factors have been implicated in the aetiology of the disease such as pelvic or 
perineal injury, pelvic interventions and colorectal diseases such as neoplasia or 
diverticulitis. As outlined above, Fournier’s gangrene demonstrates a wide variety of clinical 
presentations from slow insidious progression of scrotal swelling and pain over weeks to a 
rapid and fulminant onset within hours. Patients with full-blown Fournier’s gangrene 
usually have pronounced systemic signs such as tachycardia, tachypnoea, fever and 
possibly altered mental state. Although a wide variety of bacteria have been implicated in 
the disease (and the disease is frequently polymicrobial) the most common organisms 
isolated are Staphylococcus aureus, β-haemolytic Streptococcus, Pseudomonas sp., E. coli, 
Enterococcus and Bacteroides. The spread of infection is along fascial planes and is usually 
rapid so prompt medical and surgical therapy is mandatory. The mainstay of treatment is 
early recognition of the disease, prompt resuscitation with intravenous fluids and oxygen 
therapy, broad-spectrum high dose intravenous antibiotics, and urgent surgical 
debridement of affected areas. If there is any doubt about the diagnosis of the condition, 
radiology may be helpful in identifying gas forming organisms or areas of necrosis, and CT 
has been shown to be particularly helpful in this regard, as well as demonstrating accurately 
the extent of the disease, and the underlying cause. Due to their separate blood supply the 
testes are usually spared in Fournier’s gangrene and wide areas of skin necrosis may involve 
debridement of the scrotum, penis, thighs and anterior abdominal wall. Frequently more 
than one surgical debridement is necessary as a ‘second look’ at 24-48 hours reveals further 
areas of necrosis. Once the patient has been stabilised and there is evidence of granulation 
tissue forming in the debrided areas further treatment can now be instigated. Skin grafting, 
local and fee flaps have all been used with success in covering areas of debridement after 
Fournier’s gangrene. Recently, VAC (Vaccum Assisted Closure) therapy has been used with 
promising results in Fournier’s gangrene after debridement. 
www.intechopen.com
 
Gangrene – Current Concepts and Management Options 
 
26
Although early series reported high mortality rates for Fournier’s gangrene at around 80% 
(Stephens et al., 1993) more recent studies have shown an improvement with lower rates of 
mortality of generally less than 40% (Morpurgo, 2002, Thwaini et al., 2006). Long-term 
complications of this disease are not uncommon. Pain, sexual dysfunction, incontinence, 
scarring, and infertility have all been reported. 
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